Back to User profile » Dr Qingfeng He
Papers published by Dr Qingfeng He:
Mechanistic Physiologically Based Pharmacokinetic Modeling to Predict CYP3A4-Mediated Drug–Drug Interactions of Flumatinib as Both a Victim and a Perpetrator
Alifu M, Chu X, Zhu X, Mak WY, Zheng A, Pan C, He Q, Zhu X, Kuai Z, Xiang X
Drug Design, Development and Therapy 2026, 20:574169
Published Date: 9 May 2026
Optimized Sampling Strategies for Isoniazid in East Asian Pediatric Populations Using Population Pharmacokinetics-Informed Approaches
Ju G, Liu X, Peng Y, Yang W, Xu N, He Q, Zhang C, Chen L, Yang N, Zhang G, Li C, Su P, Zhu X, Ouyang D
Drug Design, Development and Therapy 2025, 19:3555-3576
Published Date: 1 May 2025
Parametric Population Pharmacokinetics Model Repository of Rifampicin: Model-Informed Individualized Therapy
Ju G, Liu X, Gu M, Chen L, Wang X, Li C, Yang N, Zhang G, Zhang C, Zhu X, He Q, Ouyang D
Clinical Pharmacology: Advances and Applications 2025, 17:49-78
Published Date: 15 April 2025
Prediction of Pharmacokinetic Drug–Drug Interactions Involving Anlotinib as a Victim by Using Physiologically Based Pharmacokinetic Modeling
Bu F, Cho YS, He Q, Wang X, Howlader S, Kim DH, Zhu M, Shin JG, Xiang X
Drug Design, Development and Therapy 2024, 18:4585-4600
Published Date: 15 October 2024
Model-Informed Precision Dosing of Isoniazid: Parametric Population Pharmacokinetics Model Repository
Ju G, Liu X, Yang W, Xu N, Chen L, Zhang C, He Q, Zhu X, Ouyang D
Drug Design, Development and Therapy 2024, 18:801-818
Published Date: 14 March 2024
Escitalopram Personalized Dosing: A Population Pharmacokinetics Repository Method
Liu X, Ju G, Yang W, Chen L, Xu N, He Q, Zhu X, Ouyang D
Drug Design, Development and Therapy 2023, 17:2955-2967
Published Date: 27 September 2023
